Clinical Management of Filovirus-Infected Patients

Filovirus infection presents many unique challenges to patient management. Currently no approved treatments are available, and the recommendations for supportive care are not evidence based. The austere clinical settings in which patients often present and the sporadic and at times explosive nature of filovirus outbreaks have effectively limited the information available to evaluate potential management strategies. This review will summarize the management approaches used in filovirus outbreaks and provide recommendations for collecting the information necessary for evaluating and potentially improving patient outcomes in the future.

[1]  P. Formenty,et al.  [Clinical management of patients and deceased during the Ebola outbreak from October to December 2003 in Republic of Congo]. , 2005, Bulletin de la Societe de pathologie exotique.

[2]  Jens H. Kuhn,et al.  Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations , 2010, Archives of Virology.

[3]  R. Colebunders,et al.  Organization of patient care during the Ebola hemorrhagic fever epidemic in Kikwit, Democratic Republic of the Congo, 1995. , 1999, The Journal of infectious diseases.

[4]  Sinroku Otatume,et al.  Ebola haemorrhagic fever in Zaire , 1996 .

[5]  K. Shadan,et al.  Available online: , 2012 .

[6]  M. Nanyunja,et al.  Ebola Hemorrhagic Fever Associated with Novel Virus Strain, Uganda, 2007–2008 , 2010, Emerging infectious diseases.

[7]  P. Das,et al.  Infectious disease surveillance update , 2004, The Lancet. Infectious diseases.

[8]  Barry S. Hewlett,et al.  Providing Care and Facing Death: Nursing During Ebola Outbreaks in Central Africa , 2005, Journal of transcultural nursing : official journal of the Transcultural Nursing Society.

[9]  E. Leroy,et al.  A limited outbreak of Ebola haemorrhagic fever in Etoumbi, Republic of Congo, 2005. , 2011, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[10]  Philip J. L. Gould,et al.  Filovirus outbreak detection and surveillance: lessons from Bundibugyo. , 2011, The Journal of infectious diseases.

[11]  Richard Beale,et al.  The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis , 2010, Intensive Care Medicine.

[12]  M. Bonneville,et al.  Major Expansion of γδ T Lymphocytes following Cytomegalovirus Infection in Kidney Allograft Recipients , 1999 .

[13]  R. Arthur.  Ebola in Africa--discoveries in the past decade. , 2002, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[14]  P. Formenty,et al.  Human Ebola outbreak resulting from direct exposure to fruit bats in Luebo, Democratic Republic of Congo, 2007. , 2009, Vector borne and zoonotic diseases.

[15]  C. Goldsmith,et al.  Pathologic features of filovirus infections in humans. , 1999, Current topics in microbiology and immunology.

[16]  P. Formenty,et al.  Outbreak of Marburg hemorrhagic fever among miners in Kamwenge and Ibanda Districts, Uganda, 2007. , 2011, The Journal of infectious diseases.

[17]  Mike Bray,et al.  Outbreaks of filovirus hemorrhagic fever: time to refocus on the patient. , 2007, The Journal of infectious diseases.

[18]  H. Feldmann,et al.  Symposium on Marburg and Ebola viruses. , 2001, Virus research.

[19]  Ken Alibek,et al.  Biohazard: The Chilling True Story of the Largest Covert Biological Weapons Program in the World--Told from the Inside by the Man Who Ran It , 1999 .

[20]  K. Johnson,et al.  MARBURG-VIRUS DISEASE IN KENYA , 1982, The Lancet.

[21]  J. Casals,et al.  Marburg Virus Disease , 1972, The Yale Journal of Biology and Medicine.

[22]  Alan Kemp,et al.  Marburg hemorrhagic fever associated with multiple genetic lineages of virus. , 2006, The New England journal of medicine.

[23]  S. Günther,et al.  Acute liver failure, multiorgan failure, cerebral oedema, and activation of proangiogenic and antiangiogenic factors in a case of Marburg haemorrhagic fever. , 2012, The Lancet. Infectious diseases.

[24]  Ali S Khan,et al.  Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995: determinants of survival. , 1999, The Journal of infectious diseases.

[25]  [Epidemics of Ebola haemorrhagic fever in Gabon (1994-2002). Epidemiologic aspects and considerations on control measures]. , 2004, Bulletin de la Societe de pathologie exotique.

[26]  Ghislain Moussavou,et al.  The natural history of Ebola virus in Africa. , 2005, Microbes and infection.

[27]  Mike Bray,et al.  Basic clinical and laboratory features of filoviral hemorrhagic fever. , 2011, The Journal of infectious diseases.

[28]  Outbreak(s) of Ebola haemorrhagic fever in the Republic of the Congo, January-April 2003. , 2003, Releve epidemiologique hebdomadaire.

[29]  Kathleen M. Vogel,et al.  The Soviet Biological Weapons Program: A History , 2012 .

[30]  P. Formenty,et al.  [Practical guidelines for the management of Ebola infected patients in the field]. , 2004, Medecine tropicale : revue du Corps de sante colonial.

[31]  P. Formenty,et al.  [Multiple Ebola virus haemorrhagic fever outbreaks in Gabon, from October 2001 to April 2002]. , 2005, Bulletin de la Societe de pathologie exotique.

[32]  P. Rouquet,et al.  Re-emergence of ebola haemorrhagic fever in Gabon , 2002, The Lancet.

[33]  G. Lloyd,et al.  A case of Ebola virus infection. , 1977, British medical journal.

[34]  Outbreak(s) of Ebola haemorrhagic fever, Congo and Gabon, October 2001-July 2002. , 2003, Releve epidemiologique hebdomadaire.

[35]  R. Salt,et al.  PERCUTANEOUS LUNG BIOPSY , 1976, The Lancet.

[36]  D. Heymann,et al.  Ebola hemorrhagic fever: Tandala, Zaire, 1977-1978. , 1980, The Journal of infectious diseases.

[37]  P. Debré,et al.  Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients , 1999, Nature Medicine.

[38]  M. Borchert,et al.  Filovirus hemorrhagic fever outbreak case management: a review of current and future treatment options. , 2011, The Journal of infectious diseases.

[39]  William C. Shoemaker,et al.  Meta-analysis of hemodynamic optimization in high-risk patients* , 2002, Critical care medicine.

[40]  M. Borchert,et al.  Organisation of health care during an outbreak of Marburg haemorrhagic fever in the Democratic Republic of Congo, 1999. , 2004, The Journal of infection.

[41]  J. McCormick,et al.  Ebola virus disease in southern Sudan: hospital dissemination and intrafamilial spread. , 1983, Bulletin of the World Health Organization.

[42]  Richard Beale,et al.  Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008 , 2008 .

[43]  M. Borchert,et al.  The Medecins Sans Frontieres intervention in the Marburg hemorrhagic fever epidemic, Uige, Angola, 2005. II. lessons learned in the community. , 2007, The Journal of infectious diseases.

[44]  R. Colebunders,et al.  Epidemiologic and clinical aspects of the Ebola virus epidemic in Mosango, Democratic Republic of the Congo, 1995. , 1999, The Journal of infectious diseases.

[45]  M. V. Van Kerkhove,et al.  Marburg hemorrhagic fever in Durba and Watsa, Democratic Republic of the Congo: clinical documentation, features of illness, and treatment. , 2007, The Journal of infectious diseases.

[46]  H. Ebihara,et al.  Clinical aspects of Marburg hemorrhagic fever. , 2011, Future virology.

[47]  Benjamin Jeffs,et al.  Treatment of Marburg and Ebola hemorrhagic fevers: a strategy for testing new drugs and vaccines under outbreak conditions. , 2008, Antiviral research.

[48]  E. Leroy,et al.  L es épidémies de fièvre hémorragique due au virus Ebola au Gabon ( 1994-2002 ) : , 2022 .

[49]  P. Formenty,et al.  Human infection due to Ebola virus, subtype Côte d'Ivoire: clinical and biologic presentation. , 1999, The Journal of infectious diseases.

[50]  M. Georges-Courbot,et al.  Ebola hemorrhagic fever outbreaks in Gabon, 1994-1997: epidemiologic and health control issues. , 1999, The Journal of infectious diseases.

[51]  E. Ivers,et al.  Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic Shock , 2001 .

[52]  D. Otieno,et al.  Availability of critical care resources to treat patients with severe sepsis or septic shock in Africa: a self-reported, continent-wide survey of anaesthesia providers , 2011, Critical care.

[53]  H. Tolou.  Fièvre hémorragique à virus Ebola: nouvel opus meurtrier au Soudan. , 2004 .

[54]  Javier Llorca,et al.  Impact of the Surviving Sepsis Campaign protocols on hospital length of stay and mortality in septic shock patients: Results of a three-year follow-up quasi-experimental study* , 2010, Critical care medicine.

[55]  Joel G. Breman,et al.  The epidemiology of Ebola haemorrhagic fever in Zaire 1976. , 1978 .

[56]  Nikiforov Vv,et al.  A case of a laboratory infection with Marburg fever , 1994 .

[57]  R. Colebunders,et al.  Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee. , 1999, The Journal of infectious diseases.

[58]  C. Dolea,et al.  World Health Organization , 1949, International Organization.

[59]  W. Stille,et al.  Clinical Course and Prognosis of Marburg Virus (“Green-Monkey”) Disease , 1971 .

[60]  M. Georges-Courbot,et al.  Leptospirosis and Ebola virus infection in five gold-panning villages in northeastern Gabon. , 1999, The American journal of tropical medicine and hygiene.

[61]  M. Haupt,et al.  Fluid loading increases oxygen consumption in septic patients with lactic acidosis. , 1986, The American review of respiratory disease.

[62]  M. Kindhauser,et al.  Marburg hemorrhagic fever in Angola--fighting fear and a lethal pathogen. , 2005, The New England journal of medicine.

[63]  N. Kenya-Mugisha,et al.  Severe Sepsis in Two Ugandan Hospitals: a Prospective Observational Study of Management and Outcomes in a Predominantly HIV-1 Infected Population , 2009, PloS one.

[64]  P. Rollin,et al.  Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients. , 1999, The Journal of infectious diseases.

[65]  G. Martini.  Marburg Virus Disease. Clinical Syndrome , 1971 .

[66]  P. Das.  Infectious disease surveillance update. , 2002, The Lancet. Infectious diseases.

[67]  Paul Roddy,et al.  Ebola haemorrhagic fever outbreak in Masindi District, Uganda: outbreak description and lessons learned , 2011, BMC infectious diseases.

[68]  R. Swanepoel,et al.  Unexpected Ebola virus in a tertiary setting: Clinical and epidemiologic aspects , 2000, Critical care medicine.

[69]  V. V. Nikiforov,et al.  [A case of a laboratory infection with Marburg fever]. , 1994, Zhurnal mikrobiologii, epidemiologii, i immunobiologii.

[70]  J. Breman,et al.  International Colloquium on Ebola Virus Research: summary report. , 1997, The Journal of infectious diseases.

[71]  T. Bothwell,et al.  Outbreake of Marburg virus disease in Johannesburg. , 1975, British medical journal.

[72]  K. Todorovitch,et al.  Clinical Picture of Two Patients Infected by the Marburg Vervet Virus , 1971 .

[73]  K. Ahmad.  Norwalk-like virus attacks troops in Afghanistan. , 2002, The Lancet. Infectious diseases.

[74]  M. Georges-Courbot,et al.  Inflammatory responses in Ebola virus‐infected patients , 2002, Clinical and experimental immunology.

[75]  J. Iwanicki.  Impact of the Surviving Sepsis Campaign Protocols on Hospital Length of Stay and Mortality in Septic Shock Patients: Results of a Three-year Follow-up Quasi-experimental Study , 2010 .

[76]  P. Formenty,et al.  Emergence of divergent Zaire ebola virus strains in Democratic Republic of the Congo in 2007 and 2008. , 2011, The Journal of infectious diseases.

[77]  V. A. Maksimov,et al.  [Hemorrhagic (Marburg, Ebola, Lassa, and Bolivian) fevers: epidemiology, clinical pictures, and treatment]. , 2006, Voprosy virusologii.

[78]  C. Sprung,et al.  Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock 2012 , 2013, Critical care medicine.

[79]  Filoviruses: A Compendium of 40 Years of Epidemiological, Clinical, and Laboratory Studies , 2009, Emerging Infectious Diseases.

[80]  P. Jahrling,et al.  Characterization of a new Marburg virus isolated from a 1987 fatal case in Kenya. , 1996, Archives of virology. Supplementum.

[81]  Armando Teixeira-Pinto,et al.  ResearchReducing mortality in severe sepsis with the implementation of a core 6-hour bundle : results from the Portuguese community-acquired sepsis study ( SACiUCI study ) , 2010 .

[82]  N. Gallagher,et al.  Imported case of Marburg hemorrhagic fever - Colorado, 2008. , 2009, MMWR. Morbidity and mortality weekly report.

[83]  H. Feldmann,et al.  Emergence of subtype Zaire Ebola virus in Gabon. , 1997, Virology.

[84]  Christophe Prehaud,et al.  Identification of the Ebola virus in Gabon in 1994 , 1997, The Lancet.